.
MergerLinks Header Logo

Announced

Completed

Everstone Capital completed the acquisition of a majority stake in Softgel Healthcare.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Majority

Private Equity

Pharmaceuticals

Private

Completed

Acquisition

India

Cross Border

Single Bidder

nutraceuticals

Friendly

Synopsis

Edit

Everstone Capital, the private equity arm of the Everstone Group, completed the acquisition of a majority stake in Softgel Healthcare, a manufacturer of soft gelatin capsules for Rx OTC and nutraceuticals. Financial terms were not disclosed. "We are delighted to partner with SHPL, Mr. Sulaiman and the management team led by Dr Vijay Alagappan. The company, with its strong R&D capabilities and ability to manufacture products in advanced dosage forms, is well positioned to be a global leader in the CDMO segment. We believe that Everstone's value creation playbook will help SHPL realize its global goals and propel the company into its next phase of growth," Sameer Sain, Everstone Co-founder and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US